Graviti Pharmaceuticals Private Limited recalls Bupropion Hydrochloride Extended-Release Tablets USP (XL)
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Failed Tablet/Capsule Specifications
- Products
-
- Bupropion Hydrochloride Extended-Release Tablets USP (XL)
- Where it was sold
-
Product was distributed to 1 distributor and 16 wholesalers/pharmacy retailers nationwide.
Nationwide
- Units affected
- 46,512/30 count bottles
- About this recall
- Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg, 30-count bottles, Rx Only, Mfd. by: Graviti Pharmaceuticals Private Limited, Sangareddy, Telangana, India, Dist. by: Rising Phar, NDC 16571-863-03.